GSA CAPITAL PARTNERS LLP - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 139 filers reported holding DIPLOMAT PHARMACY INC in Q3 2019. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q2 2019$192,000
-73.0%
31,584
-13.8%
0.02%
-43.6%
Q3 2018$711,000
-12.4%
36,627
-9.5%
0.04%
-20.4%
Q4 2017$812,000
+260.9%
40,450
+522.3%
0.05%
+444.4%
Q1 2015$225,0006,5000.01%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q3 2019
NameSharesValueWeighting ↓
Empirical Capital Management, LLC 479,018$9,298,0008.38%
Rhenman & Partners Asset Management AB 1,174,411$22,795,0002.28%
Capital Investment Advisory Services, LLC 153,842$2,986,0001.40%
Cortina Asset Management, LLC 1,238,420$24,038,0001.12%
Investors Research Corp 92,027$1,786,0001.02%
Matarin Capital Management, LLC 697,387$13,536,282,0000.87%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 853,687$16,570,0000.59%
RICE HALL JAMES & ASSOCIATES, LLC 809,257$15,708,0000.56%
BROADVIEW ADVISORS LLC 156,700$3,042,0000.52%
FRONTIER CAPITAL MANAGEMENT CO LLC 3,535,217$68,619,0000.44%
View complete list of DIPLOMAT PHARMACY INC shareholders